Kamada - High Quality Pharmaceuticals

Oct. 31, 2013

Kamada Reports New Data from an Extension Study of its Phase I/II Trial with Glassia in Pediatric Patients with Type 1 Diabetes

Oct. 29, 2013

Kamada Reports Third Quarter 2013 Financial Results

Upcoming Event

Kamada to participate at the Oppenheimer 24th Annual Healthcare Conference
Dec. 10-11, 2013

High Quality Pharmaceuticals

Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology.
Kamada´s product line consists of more than 10 injectable pharmaceutical products which are marketed in more than 15 countries worldwide.

Alpha-1

Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic condition which can cause serious liver disease in children and liver and/or lung disease in adults. The most common clinical presentation of Alpha-1 Deficiency is lung disease. That is the reason it is also called "Inherited Emphysema" or "Genetic COPD".

High Quality Pharmaceuticals

Alpha-1

Kamada Highlights Video